Immunotherapy for refractory B-cell acute lymphoblastic leukemia

The five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has reached about 90% with chemotherapy. Clinicians increasingly are turning to immunotherapy for relapsed/refractory B-cell ALL (B-ALL). Immunotherapy harnesses the innate power [...]

View more

Multidisciplinary care for the pregnant sickle cell disease patient

Sickle cell disease (SCD) in pregnancy raises the risk to mother and baby as well as complications of SCD, but working closely with the patient’s hematologist and a maternal-fetal medicine specialist improves the chances of […]

View more

January 2022 Norton Children’s Medical Group New Providers

Norton Children’s Medical Group welcomes these new providers. Amy E. DiPietro, M.D. Pediatric Cardiology Yuan Yuan Gong, M.D. Pediatric Emergency Medicine Katelyn Rossow, M.D. Pediatric Genetics and Genomics Patricia Walsh, PA-C Pediatric Urology Allison Reynolds, […]

View more

Study recommends genome sequencing of newborns while in the neonatal intensive care unit

Seriously ill infants with a suspected genetic disorder should undergo genome sequencing (GS) as a first-line genetic test rather than the current standard of care that can take months or years to play out, researchers [...]

View more

Don’t overlook these signs and symptoms of leukemia in children

Pediatricians can help with early detection of childhood leukemia during routine visits. Even though a patient’s signs and symptoms may appear vague, mild or suggestive of more common health conditions, they shouldn’t be ignored. In […]

View more

Classifying and treating osteogenesis imperfecta

Osteogenesis imperfecta (OI) is a clinically heterogeneous, heritable disorder characterized by increased bone fragility with a predisposition to fractures, low bone mass, bone deformities and short stature. It affects an estimate 1 in 10,000 to […]

View more

Growth, more sophisticated care mark 2021 at Norton Children’s Heart Institute

This has been a momentous year for Norton Children’s Heart Institute, affiliated with the UofL School of Medicine. We’re completing our first full year officially integrated with the former UofL Pediatrics – Cardiology practice, which […]

View more

Cardiologist aims to prevent and treat acquired heart disease in children

Preventive cardiologist Amy E. DiPietro, M.D., is joining Norton Children’s Heart Institute, affiliated with the UofL School of Medicine, as part of an expanded effort to arrest and prevent acquired heart disease in children. Dr. […]

View more

December 2021 Norton Children’s Medical Group New Providers

Aakriti Bhargava, M.D. Pediatric Emergency Medicine Victoria Magloire, M.D. Pediatric Emergency Medicine Esper Wadih, M.D. Pediatric Emergency Medicine Jessica Stone, PA-C Pediatric Cardiothoracic Surgery Chelsea Sabelhaus, APRN Pediatric Cardiology

View more

Asymptomatic pediatric cardiomyopathy makes family history important

Pediatric cardiomyopathy is progressive and may be asymptomatic up to sudden death, making family history an important tool in deciding when to refer patients, according to a cardiologist at Norton Children’s Heart Institute, affiliated with […]

View more

Delwyn E. McOmber, M.D., joins Norton Children’s Heart Institute

Pediatric cardiologist Delwyn E. McOmber, M.D., has joined Norton Children’s Heart Institute, affiliated with the UofL School of Medicine, as part of the Pediatric HeartCare Partners integration with Norton Children’s. In addition to practicing pediatric […]

View more

Reduced-toxicity myeloablative conditioning regimen effective against high-risk pediatric leukemias

A low-toxicity myeloablative conditioning regimen is safe and effective in treating high-risk leukemias, particularly myeloid disease, according to a study recently published in the journal Pediatric Blood & Cancer. Conventional myeloablative conditioning is effective at […]

View more

Search our entire site.